Cargando…
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Advancements in the field of cellular immunotherapy have accelerated in recent years and have changed the treatment landscape for a variety of hematologic malignancies. Cellular immunotherapy strategies exploit the patient’s immune system to kill cancer cells. The successful use of CD19 chimeric ant...
Autores principales: | Xu, Zhengli, Huang, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610149/ https://www.ncbi.nlm.nih.gov/pubmed/34351724 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0801 |
Ejemplares similares
-
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022) -
Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017) -
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
por: Tang, Lu, et al.
Publicado: (2023) -
Cellular immunotherapy for refractory hematological malignancies
por: Reagan, John L, et al.
Publicado: (2013) -
Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021)